Directory Of Approved Biopharmaceuticals Stefania Spada Gary Walsh by Stefania Spada; Gary Walsh 9780203303429, 0203303423 instant download after payment.

Until now, accessing data on the list of currently approved bio biopharmaceuticals has been laborious and patchy. This volume brings together key information on various aspects of these compounds, including: scientific and trade name, year and regions approved, approved indications, manudacturer, marketing right, method of manufacture, scientific overview, and therapeutic properties. This comprehensive and consistent approach will save professionals in the pharmaceutical industry hiurs spent trawling the literature - and provides a singlr resource for future reference.
Content: Book Cover; Half-Title; Title; Copyright; Dedication; Preface; Authors; Table of Contents; Actimmune; Activase; Aldurazyme; Ambirix; Amevive; Avonex; BeneFIX; Beromun; Betaferon/Betaseron; Bexxar; Bio-Tropin (Tev-Tropin or Zomacton); Bioclate; CEA-Scan; Cerezyme; Comvax; Ecokinase (withdrawn from market); Enbrel; Engerix-B; Epogen/Procrit; Fabrazyme; Fasturtec/Elitek; Forcaltonin; Forsteo/Forteo; Genotropin; GlucaGen; Glucagon; Gonal-F; HBVAXPRO; Helixate NexGen/Helixate FS/Kogenate FS; Hepacare (withdrawn from market); Herceptin; Hexavac; Humalog; HumaSPECT; Humatrope; Humira; Humulin. Indimacis 125 (withdrawn from market)InductOs; INFANRIX HepB; Infanrix Hexa; Infanrix Penta/Pediarix; Infergen; InFUSE Bone Graft/LT-CAGE Lumbar Tapered Fusion Device'; Insuman; Intron A; Kineret; Lantus; Leukine; LeukoScan; Liprolog (withdrawn from market); Luveris; LYMErix (withdrawn from market); MabCampath/Campath-1H; MabThera/Rituxan; Metalyse/TNKase; Mylotarg; Myoscint (withdrawn from market); Natrecor; NeoRecormon; Nespo/Aranesp; Neulasta; Neumega; Neupogen; Nordi.
Abstract: Until now, accessing data on the list of currently approved bio biopharmaceuticals has been laborious and patchy. This volume brings together key information on various aspects of these compounds, including: scientific and trade name, year and regions approved, approved indications, manudacturer, marketing right, method of manufacture, scientific overview, and therapeutic properties. This comprehensive and consistent approach will save professionals in the pharmaceutical industry hiurs spent trawling the literature - and provides a singlr resource for future reference